Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.17B |
| 2 |
Microsoft
MSFT
|
+$619M |
| 3 |
Apple
AAPL
|
+$377M |
| 4 |
Booking.com
BKNG
|
+$319M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.48B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$896M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$599M |
| 4 |
Citigroup
C
|
+$467M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.29% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.55% |
| 4 | Financials | 1.15% |
| 5 | Healthcare | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMP
11076
CALL
Immutep
IMMP
$56.1M
| $77.3K | ﹤0.01% |
44,200
+28,700
| +185% | +$56.9K |
|
11077
CALL
Imperial Petroleum
IMPP
$235M
| $77.3K | ﹤0.01% |
21,473
-52,254
| -71% | -$283K |
|
11078
PUT
American Superconductor
AMSC
$1.38B
| $77.3K | ﹤0.01% |
21,000
+5,700
| +37% | +$22.3K |
|
|
MIMO
11079
DELISTED
Airspan Networks Holdings Inc
MIMO
| $77.2K | ﹤0.01% |
58,900
+28,193
| +92% | +$55K |
|
11080
CALL
Curis
CRIS
$3.61M
| $76.9K | ﹤0.01% |
350
-113
| -24% | -$33.1K |
|
11081
CALL
Sphere 3D
ANY
$19.2M
| $76.9K | ﹤0.01% |
3,926
-3,403
| -46% | -$88.7K |
|
|
HIVE
11082
PUT
HIVE Digital Technologies
HIVE
$760M
| $76.9K | ﹤0.01% |
53,400
-222,500
| -81% | -$568K |
|
|
SGMA
11083
DELISTED
Sigmatron International
SGMA
| $76.6K | ﹤0.01% |
+19,952
| New | +$95.9K |
|
11084
Oil States International
OIS
$519M
| $76.6K | ﹤0.01% |
10,270
-95,199
| -90% | -$589K |
|
|
BTTX
11085
PUT
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
| $76.6K | ﹤0.01% |
68,400
-18,400
| -21% | -$27.1K |
|
|
CVAC
11086
PUT
DELISTED
CureVac
CVAC
| $76.6K | ﹤0.01% |
12,700
-69,100
| -84% | -$511K |
|
11087
Arcadia Biosciences
RKDA
$1.28M
| $76.5K | ﹤0.01% |
7,060
+3,241
| +85% | +$46.2K |
|
11088
AXT Inc
AXTI
$3.84B
| $76.5K | ﹤0.01% |
17,469
+5,873
| +51% | +$28.6K |
|
11089
CALL
Galectin Therapeutics
GALT
$405M
| $76.5K | ﹤0.01% |
67,700
-91,100
| -57% | -$121K |
|
|
EDVA
11090
Endovia Health Sciences, Inc.
EDVA
$1.99M
| $76.5K | ﹤0.01% |
+497
| New | +$87.2K |
|
|
VBIV
11091
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $76.5K | ﹤0.01% |
6,519
-783
| -11% | -$13.8K |
|
11092
Idaho Strategic Resources
IDR
$512M
| $76.4K | ﹤0.01% |
13,403
-30,550
| -70% | -$171K |
|
11093
PUT
Outdoor Holding Co
POWW
$253M
| $76.3K | ﹤0.01% |
44,100
-73,800
| -63% | -$186K |
|
|
HIVE
11094
HIVE Digital Technologies
HIVE
$760M
| $76.3K | ﹤0.01% |
52,960
-102,533
| -66% | -$262K |
|
|
EOD
11095
Allspring Global Dividend Opportunity Fund
EOD
$288M
| $76.2K | ﹤0.01% |
17,440
-11,880
| -41% | -$54.9K |
|
|
BLUE
11096
CALL
DELISTED
bluebird bio
BLUE
| $76.1K | ﹤0.01% |
550
-5,335
| -91% | -$752K |
|
11097
TAT Technologies
TATT
$472M
| $76.1K | ﹤0.01% |
14,094
-54
| -0.4% | -$328 |
|
11098
CALL
Atara Biotherapeutics
ATRA
$92.3M
| $76.1K | ﹤0.01% |
928
+504
| +119% | +$52.5K |
|
11099
Vera Bradley
VRA
$94.1M
| $76.1K | ﹤0.01% |
16,789
-157,623
| -90% | -$576K |
|
|
EMAN
11100
CALL
DELISTED
eMagin Corporation
EMAN
| $76K | ﹤0.01% |
89,400
+62,000
| +226% | +$51K |
|
Similar funds
Jeff Yass's Q4 2022 Portfolio in Review
As of Q4 2022, Jeff Yass held 14,748 positions worth $395B, up 2.2% from $387B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q4 2022 filing shows 1,670 new, 4,598 increased, 5,764 reduced and 2,486 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M. The largest sale was Amazon, an estimated $1.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2022 buy was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M.
- Jeff Yass added most to Tesla in Q4 2022, an estimated $2.17B increase.
- Jeff Yass's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.48B.
- Jeff Yass fully exited Twitter, Inc. in Q4 2022, selling an estimated $76M.
- Jeff Yass's ten largest holdings make up 27% of its $395B portfolio in Q4 2022.
- Jeff Yass opened 1,670 new positions and closed 2,486 in Q4 2022.
- Jeff Yass's portfolio value rose 2.2% quarter-over-quarter to $395B.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.